Abella, V., Scotece, M., Conde, J., Pino, J., Gonzalez-Gay, M. A., Gomez-Reino, J. J., et al. (2017). Leptin in the interplay of inflammation, metabolism and immune system disorders. Nat. Rev. Rheumatol. 13 (2), 100–109. doi: 10.1038/ nrrheum.209
Arnoldussen, I. A., Kiliaan, A. J., and Gustafson, D. R. (2014). Obesity and dementia: adipokines interact with the brain. Eur. Neuropsychopharmacol. 24 (12), 1982–1999. doi: 10.1016/j.euroneuro.2014.03.002
Asai, Y., Yamada, T., Tsukita, S., Takahashi, K., Maekawa, M., Honma, M., et al. (2017). Activation of the Hypoxia Inducible Factor 1alpha Subunit Pathway in Steatotic Liver Contributes to Formation of Cholesterol Gallstones. Gastroenterology 152 (6), 1521–1535 e1528. doi: 10.1053/j.gastro.2017.01.001 Avalos, Y., Kerr, B., Maliqueo, M., and Dorfman, M. (2018). Cell and molecular mechanisms behind diet-induced hypothalamic inflammation and obesity. J. Neuroendocrinol. 30 (10), e12598. doi: 10.1111/jne.12598
Bodary, P. F. (2007). Links between adipose tissue and thrombosis in the mouse. Arterioscler. Thromb. Vasc. Biol. 27 (11), 2284–2291. doi: 10.1161/ATVBAHA. 107.148221
Boe, A. E., Eren, M., Murphy, S. B., Kamide, C. E., Ichimura, A., Terry, D., et al. (2013). Plasminogen activator inhibitor-1 antagonist TM5441 attenuates Nomega-nitro-L-arginine methyl ester-induced hypertension and vascular senescence. Circulation 128 (21), 2318–2324. doi: 10.1161/CIRCULATIONAHA. 113.003192
Chaudhry, S., Bernardes, M., Harris, P. E., and Maffei, A. (2016). Gastrointestinal dopamine as an anti-incretin and its possible role in bypass surgery as therapy for type 2 diabetes with associated obesity. Minerva Endocrinol. 41 (1), 43–56. Chiba, Y., Yamada, T., Tsukita, S., Takahashi, K., Munakata, Y., Shirai, Y., et al. (2016). Dapagliflozin, a Sodium-Glucose Co-Transporter 2 Inhibitor, Acutely Reduces Energy Expenditure in BAT via Neural Signals in Mice. PloS One 11 (3), e0150756. doi: 10.1371/journal.pone.0150756
Cui, H., Lopez, M., and Rahmouni, K. (2017). The cellular and molecular bases of leptin and ghrelin resistance in obesity. Nat. Rev. Endocrinol. 13 (6), 338–351. doi: 10.1038/nrendo.2016.222
Drareni, K., Ballaire, R., Barilla, S., Mathew, M. J., Toubal, A., Fan, R., et al. (2018). GPS2 Deficiency Triggers Maladaptive White Adipose Tissue Expansion in Obesity via HIF1A Activation. Cell Rep. 242957-2971 (11), e2956. doi: 10.1016/ j.celrep.2018.08.032
Eren, M., Boe, A. E., Murphy, S. B., Place, A. T., Nagpal, V., Morales-Nebreda, L., et al. (2014). PAI-1-regulated extracellular proteolysis governs senescence and survival in Klotho mice. Proc. Natl. Acad. Sci. U. S. A. 111 (19), 7090– 7095. doi: 10.1073/pnas.1321942111
Friedman, J. (2016). The long road to leptin. J. Clin. Invest. 126 (12), 4727–4734. doi: 10.1172/JCI91578
Jeon, H., Kim, J. H., Kim, J. H., Lee, W. H., Lee, M. S., and Suk, K. (2012). Plasminogen activator inhibitor type 1 regulates microglial motility and phagocytic activity. J. Neuroinflamm. 9, 149. doi: 10.1186/1742-2094-9-149
Jeong, B. Y., Uddin, M. J., Park, J. H., Lee, J. H., Lee, H. B., Miyata, T., et al. (2016). Novel Plasminogen Activator Inhibitor-1 Inhibitors Prevent Diabetic Kidney Injury in a Mouse Model. PloS One 11 (6), e0157012. doi: 10.1371/journal.pone.0157012
Kabra, D. G., Pfuhlmann, K., Garcia-Caceres, C., Schriever, S. C., Casquero Garcia, V., Kebede, A. F., et al. (2016). Hypothalamic leptin action is mediated by histone deacetylase 5. Nat. Commun. 7, 10782. doi: 10.1038/ncomms10782
Katagiri, H., Yamada, T., and Oka, Y. (2007). Adiposity and cardiovascular disorders: disturbance of the regulatory system consisting of humoral and neuronal signals. Circ. Res. 101 (1), 27–39. doi: 10.1161/CIRCRESAHA. 107.151621
Kenny, S., Gamble, J., Lyons, S., Vlatkovic, N., Dimaline, R., Varro, A., et al. (2013). Gastric expression of plasminogen activator inhibitor (PAI)-1 is associated with hyperphagia and obesity in mice. Endocrinology 154 (2), 718–726. doi: 10.1210/en.2012-1913
Khandekar, M. J., Cohen, P., and Spiegelman, B. M. (2011). Molecular mechanisms of cancer development in obesity. Nat. Rev. Cancer 11 (12), 886–895. doi: 10.1038/nrc3174
Liu, J., Lee, J., Salazar Hernandez, M. A., Mazitschek, R., and Ozcan, U. (2015). Treatment of obesity with celastrol. Cell 161 (5), 999–1011. doi: 10.1016/ j.cell.2015.05.011
Loh, K., Fukushima, A., Zhang, X., Galic, S., Briggs, D., Enriori, P. J., et al. (2011). Elevated hypothalamic TCPTP in obesity contributes to cellular leptin resistance. Cell Metab. 14 (5), 684–699. doi: 10.1016/j.cmet.2011.09.011
Ma, L. J., Mao, S. L., Taylor, K. L., Kanjanabuch, T., Guan, Y., Zhang, Y., et al. (2004). Prevention of obesity and insulin resistance in mice lacking plasminogen activator inhibitor 1. Diabetes 53 (2), 336–346. doi: 10.2337/diabetes.53.2.336
Pelisch, N., Dan, T., Ichimura, A., Sekiguchi, H., Vaughan, D. E., van Ypersele de Strihou, C., et al. (2015). Plasminogen Activator Inhibitor-1 Antagonist TM5484 Attenuates Demyelination and Axonal Degeneration in a Mice Model of Multiple Sclerosis. PloS One 10 (4), e0124510. doi: 10.1371/journal.pone.0124510
Piao, L., Jung, I., Huh, J. Y., Miyata, T., and Ha, H. (2016). A novel plasminogen activator inhibitor-1 inhibitor, TM5441, protects against high-fat diet-induced obesity and adipocyte injury in mice. Br. J. Pharmacol. 173 (17), 2622–2632. doi: 10.1111/bph.13541
Pierroz, D. D., Ziotopoulou, M., Ungsunan, L., Moschos, S., Flier, J. S., and Mantzoros, C. S. (2002). Effects of acute and chronic administration of the melanocortin agonist MTII in mice with diet-induced obesity. Diabetes 51 (5), 1337–1345. doi: 10.2337/diabetes.51.5.1337
Rezai-Zadeh, K., and Munzberg, H. (2013). Integration of sensory information via central thermoregulatory leptin targets. Physiol. Behav. 121, 49–55. doi: 10.1016/j.physbeh.2013.02.014
Saltiel, A. R. (2016). New therapeutic approaches for the treatment of obesity. Sci.
Transl. Med. 8 (323), 323rv322. doi: 10.1126/scitranslmed.aad1811 Takahashi, K., Yamada, T., Tsukita, S., Kaneko, K., Shirai, Y., Munakata, Y., et al. (2013). Chronic mild stress alters circadian expressions of molecular clock genes in the liver. Am. J. Physiol. Endocrinol. Metab. 304 (3), E301–E309. doi: 10.1152/ajpendo.00388.2012
Thaler, J. P., Yi, C. X., Schur, E. A., Guyenet, S. J., Hwang, B. H., Dietrich, M. O., et al. (2012). Obesity is associated with hypothalamic injury in rodents and humans. J. Clin. Invest. 122 (1), 153–162. doi: 10.1172/JCI59660
Timper, K., and Bruning, J. C. (2017). Hypothalamic circuits regulating appetite and energy homeostasis: pathways to obesity. Dis. Model Mech. 10 (6), 679– 689. doi: 10.1242/dmm.026609
Tsukita, S., Yamada, T., Uno, K., Takahashi, K., Kaneko, K., Ishigaki, Y., et al. (2012). Hepatic glucokinase modulates obesity predisposition by regulating BAT thermogenesis via neural signals. Cell Metab. 16 (6), 825–832. doi: 10.1016/j.cmet.2012.11.006
Tsukita, S., Yamada, T., Takahashi, K., Munakata, Y., Hosaka, S., Takahashi, H., et al. (2017). MicroRNAs 106b and 222 Improve Hyperglycemia in a Mouse Model of Insulin-Deficient Diabetes via Pancreatic beta-Cell Proliferation. EBioMedicine 15, 163–172. doi: 10.1016/j.ebiom.2016.12.002
Uno, K., Katagiri, H., Yamada, T., Ishigaki, Y., Ogihara, T., Imai, J., et al. (2006). Neuronal pathway from the liver modulates energy expenditure and systemic insulin sensitivity. Science 312 (5780), 1656–1659. doi: 10.1126/science. 1126010
Wang, L., Chen, L., Liu, Z., Liu, Y., Luo, M., Chen, N., et al. (2018). PAI-1 Exacerbates White Adipose Tissue Dysfunction and Metabolic Dysregulation in High Fat Diet-Induced Obesity. Front. Pharmacol. 9, 1087–1094. doi: 10.3389/fphar.2018.01087
Yamada, T., Katagiri, H., Ishigaki, Y., Ogihara, T., Imai, J., Uno, K., et al. (2006). Signals from intra-abdominal fat modulate insulin and leptin sensitivity through different mechanisms: neuronal involvement in food-intake regulation. Cell Metab. 3 (3), 223–229. doi: 10.1016/j.cmet.2006.02.001
Yamada, T., Oka, Y., and Katagiri, H. (2008). Inter-organ metabolic communication involved in energy homeostasis: potential therapeutic targets for obesity and metabolic syndrome. Pharmacol. Ther. 117 (1), 188–198. doi: 10.1016/j.pharmthera.2007.09.006
Yamada, T., Tsukita, S., and Katagiri, H. (2013). Identification of a novel interorgan mechanism favoring energy storage in overnutrition. Adipocyte 2 (4), 281–284. doi: 10.4161/adip.25499